Investigating Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) reported in association with HIV antiretroviral therapy: An analysis of the FDA Adverse Event Reporting System
Open Access
- 13 August 2024
- journal article
- letter
- Published by Wiley in JEADV Clinical Practice
- Vol. 3 (5) , 1701-1704
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated reviewFrontiers in Medicine, 2023
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in AdultsJAMA, 2023
- Rate of DRESS Syndrome With Raltegravir and Role of the HLA-B*53:01 AlleleJAIDS Journal of Acquired Immune Deficiency Syndromes, 2020
- Drug reaction with eosinophilia and systemic symptoms related to antiretroviral treatment in human immunodeficiency virus patientsIndian Journal of Sexually Transmitted Diseases and AIDS, 2017
- Data Mining of the Public Version of the FDA Adverse Event Reporting SystemInternational Journal of Medical Sciences, 2013